Navigation Links
Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting

ear ended December 31, 2006 and in Pharmion's other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and Pharmion undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Pharmion also disclaims any duty to comment upon or correct information that may be contained in reports published by the investment community.

CONTACT: Breanna Burkart or Anna Sussman, Directors, Investor Relationsand Corporate Communications, of Pharmion Corporation, +1-720-564-9144 or+1-720-564-9143; or Tara May of Pharmion Corporation, On-site mediacontact, +1-303-646-7832

Web site: http://www.pharmion.com/

Ticker Symbol: (NASDAQ-NMS:PHRM)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
(Date:11/6/2009)... PARIS, November 6 , - ...Linezolid for the,Treatment of Multi-Resistant Sta...vexel, a speciality pharmaceutical company focused...tics designed to overcome the significant global,p...at its most advanced oral,antibacterial NXL103 (fl...
(Date:11/5/2009)...OINT RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCal...PT ), a specialty pharmaceutical company focused o...tary products that address important therapeutic n... it will host a webcast and teleconference with ma...esults on Thursday, November 12, 2009, at 5:00 p.m...
(Date:11/5/2009)...ULLERTON, Calif., Nov. 5 Renee Cob...ate professor of dermatology at the University of ...nts are experiencing tremendous results with Therm...ed for skin tightening and contouring, features a ...efficacy and improves patient comfort. ,, "The...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2What are the most effective ways of promoting physical exercise in adults 3F 51564 1What are the most effective ways of promoting physical exercise in adults 3F 51564 2What are the most effective ways of promoting physical exercise in adults 3F 51564 3Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 1Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 2Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 3Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 4Pelosi Statement on Appointment of Dr Regina Benjamin as Surgeon General of the United States 51560 1
...or Cancer Research meeting indicate that technolo...-water-soluble drugs to treat cancer and possibly ...r Pharmaceuticals today,reported results on a nove...pable of dissolving in water (hydrophobic drugs) i...ation. These findings allow the company to,combine...
...MOND, Va., April 16 Insmed Inc. (Nasdaq:,INSM), a...ticals, today,announced that it has received appro...care products Regulatory Agency (MHRA) to initiate...n biologic (FOB) product candidate.,Insmed,s INS-1...a follow-on,biologic of the FDA-approved product N...
Other Medicine Technology:Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 2Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4
(Date:11/8/2009)...is won," said Dr. Charmaine Yoest. ,, WASHINGT... 240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahlke... mandates and funding in HR 3962 passed on the Hou...resident and CEO Dr. Charmaine Yoest said, "The pa...ife Americans across this country who have flooded...
(Date:11/8/2009)...re/ -- The following was released today by Randall... ,, Mr. Terry and his associates from around t...g by abortion out of any health care bill for mont... step to victory -- a touchdown in the first quart...ur rejoicing must be tempered by reality. The Sena...
(Date:11/7/2009)...re/ -- Karen Ignagni, President and CEO of America...lowing statement today on House passage of H.R. 39...sive health care reform, and we have contributed t... of how health insurance is provided. Earlier this...n of pre-existing condition exclusions, no longer ...
(Date:11/7/2009)... this a "defining moment" for the American Medical...ack, M.D., today addressed medical students and fe...ty societies at the opening of the AMA,s semi-annu...rm will top the agenda. ,, (Logo: http://www...., "Over the next 72 hours, this AMA House of Deleg...
(Date:11/7/2009)...re/ -- Speaker Nancy Pelosi and Democratic leaders...g a Democratic Whip meeting with President Obama i... opening remarks: ,, "Thank you very much, Mr....eive the President of the United States on this da... making progress for the American people. ,, ...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...roteins could detect disease sooner, when it,s mor... News) -- Five proteins linked to early developmen.... researchers, who said the finding is a step forw...e first time, protein changes associated with earl...
...Friday 13 June 2008: The TRAF1/C5 locus on chromos... autoimmune diseases including type 1 diabetes and...new data presented today at EULAR 2008, the Annual...nt component 5) are both immune related genes thou...
...Friday 13 June 2008: Tocilizumab plus methotrexate...acy and safety in patients with moderate to severe... responded to anti-tumour necrosis factor (anti-TN...cilizumab, an anti-interleukin (IL)-6 receptor mon...
...be Smoke-Free in 90 Days, HARRISBURG, Pa., June 1...w the Clean Indoor Air Act, which will protect,Pen...ndhand smoke by,prohibiting smoking in most public...islators who refused to quit working until we had ...
...ents near scene affected years later, with those i...(HealthDay News) -- Two to three years after the W... residents who lived near the site had signs of po...hree times the usual rate and matches the 12.4 per...
...Friday 13 June 2008: A new DNA microarray chip can...ts with rheumatoid arthritis (RA), as presented to...pean League Against Rheumatism in Paris, France. T... and prognosis and thereby guide decisions on the ...
Other Medicine News:Health News:Pancreatic Cancer Biomarkers Found 2Health News:Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases 2Health News:30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 3Health News:PTSD High Among Witnesses to 9/11 2Health News:Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis 2
Cruchfield Skull Traction Tong
...ll base surgery. Complete implant selection for: c... pediatric neurosurgery, bony defects of the masto...o trauma. Dedicated neuro/skull base system combin...RI and CT compatible implants. Available with the ...
Crutchfield Skull Traction Tong
Ralk Hand Drill
Medicine Products: